Harvard Biosciences bought Genomic Solutions in 2002, one of some 20 acquisitions the company has completed in the seven years its management team has been on board.

Now almost two years later, Harvard Bio is still trying to digest the $27 million purchase of the small molecular biology tools vendor.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.